The cytoplasmic lattice in mammalian eggs sequesters ubiquitination machinery and tubulin in reserve

The cytoplasmic lattice (CPL) in mammalian eggs is essential for early embryonic development, but its molecular components, structural organization, and functional capacity have remained elusive. Here, using cryo-electron microscopy, we show that the CPL filament in mouse eggs contains repeating units with a periodicity of ~37 nm, and determine its high-resolution, native structure and complete subunit composition. The CPL architecture organizes maternal-effect proteins, ubiquitination machinery, and tubulin into a highly structured reservoir. Maternal-effect proteins form the scaffold of the CPL to sequester a UBE2D-UHRF1 E2-E3 ubiquitination module and three distinct FBXW E3 ubiquitin ligases, notably all in activity-excluded states. The CPL further contains an αβ-tubulin heterodimer in a GTP-bound state with a calcium ion coordinated to α-tubulin, suggesting microtubule assembly-competent tubulin held in reserve. The CPL structure is capped at each end by a terminal unit that lacks a PADI6 dimer, a scaffold component, thereby preventing further oligomerization. Interactions between maternal-effect proteins in adjacent CPL units promote the assembly of a three-dimensional lattice in the egg cytoplasm. Taken together, our work defines how CPL assembly and architecture prime mammalian eggs for ubiquitin-mediated protein degradation and cytoskeletal remodeling during the egg-to-embryo transition. ### Competing Interest Statement The authors have declared no competing interest. Vallee Scholars Award, VS-2024-56 Pew Scholars Award, 00037689 National Institutes of Health, R35GM146725 Lalor Foundation Postdoctoral Fellowship NIH NICHD grant, R00HD104924 David Sokal Innovation Award of Male Contraceptive Initiative, 2024-303 Yale discretionary fund

Modern synthetic pathways towards eribulin and its subunits

Beilstein Journal of Organic Chemistry

Checking your browser - reCAPTCHA

Modern synthetic pathways towards eribulin and its subunits

Beilstein Journal of Organic Chemistry

Checking your browser - reCAPTCHA

Cytoplasmic Fidgetin Induces Noncanonical Activation of β-catenin to Support Cancer Progression

Abstract. The subcellular localization, together with the expression level, determines the biological effects and physiological functions of proteins. Fidgetin (FIGN) is a microtubule-severing protein that plays a critical role in cytoskeletal dynamics, and it predominantly localizes in the nucleus in normal cells. Here, we observed FIGN largely in the cytoplasm of malignant cells, and increased cytoplasmic FIGN was significantly associated with clinicopathological features and poor prognosis in breast carcinoma, hepatocellular carcinoma and lung adenocarcinoma. Cytoplasmic FIGN promoted tumor development, growth, and metastasis in multiple mouse models, and it facilitated proliferation, colony formation, migration, and invasion of multiple cancer cells in vitro. FIGN interacted with MYH2 and HNRNPA2B1; MYH2 regulated the nucleocytoplasmic distribution of FIGN and its effects on cancer progression, while cytoplasmic FIGN stabilized β-catenin mRNA and promoted malignant biological behaviors in an HNRNPA2B1-dependent manner. Furthermore, an iRGD-fused peptide was designed to block the MYH2-FIGN interface, which facilitated FIGN translocation to the nucleus and suppressed cancer progression. Together, this study demonstrates a noncanonical mechanism for β-catenin activation by cytoplasmic FIGN that drives cancer progression.

Cytoplasmic Fidgetin Induces Noncanonical Activation of β-catenin to Support Cancer Progression

Abstract. The subcellular localization, together with the expression level, determines the biological effects and physiological functions of proteins. Fidgetin (FIGN) is a microtubule-severing protein that plays a critical role in cytoskeletal dynamics, and it predominantly localizes in the nucleus in normal cells. Here, we observed FIGN largely in the cytoplasm of malignant cells, and increased cytoplasmic FIGN was significantly associated with clinicopathological features and poor prognosis in breast carcinoma, hepatocellular carcinoma and lung adenocarcinoma. Cytoplasmic FIGN promoted tumor development, growth, and metastasis in multiple mouse models, and it facilitated proliferation, colony formation, migration, and invasion of multiple cancer cells in vitro. FIGN interacted with MYH2 and HNRNPA2B1; MYH2 regulated the nucleocytoplasmic distribution of FIGN and its effects on cancer progression, while cytoplasmic FIGN stabilized β-catenin mRNA and promoted malignant biological behaviors in an HNRNPA2B1-dependent manner. Furthermore, an iRGD-fused peptide was designed to block the MYH2-FIGN interface, which facilitated FIGN translocation to the nucleus and suppressed cancer progression. Together, this study demonstrates a noncanonical mechanism for β-catenin activation by cytoplasmic FIGN that drives cancer progression.